Sentez CRO

Sentez CRO

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sentez CRO is a private, revenue-generating service provider operating as a full-service contract research organization in Turkey's growing life sciences sector. Founded in 2010, it leverages its location and experienced team to offer clinical research services primarily focused on drug delivery and small molecules for pharmaceutical clients. The company's business model is built on providing reliable, economical R&D support, aiming to establish long-term partnerships. Its strategic position in Istanbul provides access to a significant patient population and a bridge between European and emerging markets.

Drug DeliverySmall Molecules

Technology Platform

Integrated full-service CRO platform specializing in drug delivery and small molecule development, offering clinical trial management, regulatory affairs, data management, pharmacovigilance, and medical writing services.

Opportunities

Leveraging Turkey's large, diverse patient population and cost-effective operational environment to attract international clinical trials.
Growing demand for outsourcing in small molecule and complex drug delivery development provides a steady client stream.
Potential to act as a strategic gateway for sponsors targeting both European and emerging markets.

Risk Factors

Intense competition from large global CROs and other regional providers.
Operational risks related to clinical trial quality, data integrity, and regulatory compliance in a evolving Turkish landscape.
Dependency on the R&D spending cycles of pharmaceutical and biotech clients.

Competitive Landscape

Sentez operates in a highly competitive global CRO market dominated by large multinational firms (e.g., IQVIA, LabCorp, ICON, PPD) with vast resources. Its differentiation lies in being a specialized, local full-service provider in Turkey, offering deep regional expertise, cost advantages, and personalized service to mid-sized and smaller sponsors, competing against other regional CROs and the local offices of global giants.